Make your money go further for just 25p per day

AIM IHT

Not so wacky, but still unusual!

21/10/2021 · Alumasc (ALU)  · Celebrus Technologies (CLBS)  · Solid State (SOLI)  · Synairgen   · System1 (SYS1)  · Tatton Asset Management (TAM) 

AIM AIM Inheritance Tax potential UK

Crazy chemist

A new strategy appears to be delivering for an unusual business covered here. Elsewhere, a small AIM company developing a drug to treat Covid received positive news, but it remains a bit of a binary investment call. Read on here for our thoughts on these and other updates from the fast-moving world of AIM.


Tatton Asset: doing very nicely

The latest update from Tatton Asset Management (AIM: TAM), the investment management and IFA support services business, suggests all is going well, although they didn’t provide a huge amount of informatio.

For the six months ending 30 September 2021 total assets under management increased by 20.0% or £1.797 billion to £10.787 billion, with organic growth contributing 12.8%.

Paradigm, the Group's IFA support services business, also continued to…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alumasc

Bonkers Bargains: Budget uncertainty brings small downgrade

24/10/2025 · Company Insights

Despite the gloom surrounding the UK construction materials sector, this sustainable building products group has delivered excellent growth…


Episode 36 of the Investor’s Champion Podcast

05/10/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee discuss intriguing investment opportunities, focusing…


More on Celebrus Technologies

Diworsification? | Accounting confusion | Contract demands

22/10/2025 · Company Insights

A provider of maritime surveillance systems is finally delivering on its considerable potential, although, with plenty…


Defence winner | Cash flow concerns | Plenty going on

18/07/2025 · Company Insights

News covered here includes our assessment of a positive trading update from a company benefitting from…


More on Solid State

On the right track | Professional appeal | Strange name

05/11/2025 · Company Insights

News covered in our small cap update here includes our assessment of results from a popular…


Ahead again and cash builds | Too big a deal | Shock warning

15/11/2024 · Company Insights

Another positive update from one of AIM’s oldest companies has brought another upgrade and lifted the…


More on Synairgen

Not so wacky, but still unusual!

21/10/2021 · Company Insights

A new strategy appears to be delivering for an unusual business covered here. Elsewhere, a small…


Coronavirus impact: 20 July - positive news from a respiratory drug

20/07/2020 · Company Insights

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


More on System1

Stonking Small Cap strength | Big dividend payer | Energy growth

22/01/2025 · Company Insights

News covered here includes our assessment of plenty of trading updates, including another upgrade for a…


Elderly loss-making brands | Stunning growth

03/12/2024 · Company Insights

A company covered here has made another acquisition of an elderly UK consumer brand – is…


More on Tatton Asset Management

Upgrades galore | Technical knowledge needed

19/11/2025 · Company Insights

News covered here includes yet more impressive results from an investment management group which continues to…


American growth | Appealing dividends | Musical chairs

14/10/2025 · Company Insights

A manufacturer of infection prevention products looks well-placed to grow in North America, but it might…


More Company Insights

Another share buyback | Not suited to public markets

20/11/2025 · Jet2 · Manolete Partners · MHA · PCI- PAL

Upgrades galore | Technical knowledge needed

Bonkers Bargains: operational improvements coming through

17/11/2025 · James Cropper

More on Alumasc

Bonkers Bargains: Budget uncertainty brings small downgrade

Episode 36 of the Investor’s Champion Podcast

Episode 32 of the Investor’s Champion Podcast

Episode 27 of the Investor’s Champion podcast

More on Celebrus Technologies

Diworsification? | Accounting confusion | Contract demands

Defence winner | Cash flow concerns | Plenty going on

Bonkers Bargain drama | Accounting manoeuvres | Automotive excellence

Data specialist is looking good

More on Solid State

On the right track | Professional appeal | Strange name

Ahead again and cash builds | Too big a deal | Shock warning

Challenging outlooks | Reassuringly boring | Hidden value

Fund raise | Excellent offering | Renewed focus

More on Synairgen

Not so wacky, but still unusual!

Coronavirus impact: 20 July - positive news from a respiratory drug

Coronavirus impact: 18 June - a big day of news from Covid-19 testers

More on System1

Stonking Small Cap strength | Big dividend payer | Energy growth

Elderly loss-making brands | Stunning growth

Excellent travel companies | More fund manager appeal

Episode 25 of the Investor’s Champion Podcast

More on Tatton Asset Management

Upgrades galore | Technical knowledge needed

American growth | Appealing dividends | Musical chairs

Will it survive? | Largest contract to date | Stunning results

Defying the gloom | Selling-up | Bonkers Bargain update

More Company Insights

Another share buyback | Not suited to public markets
Upgrades galore | Technical knowledge needed
Bonkers Bargains: operational improvements coming through

Sign-up to our free email updates

SIGN UP